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INTRODUCTION:  Cellular  ﬁbrohistiocytoma  (CFH)  is  a  type  of  ﬁbrohistiocytic  tumor  that  commonly  occurs
in  the dermis  and  superﬁcial  subcutis.  The  designation  is  used  for lesions  that  show  increased  cellularity
with  a fascicular  growth  pattern  and  frequent  extension.  Our  search  of  literature  only  revealed  one case
of a  primary  CFH  of  the  lung.  We  experienced  a rare  patient  with  a primary  CFH  of the  lung.
PRESENTATION  OF  CASE:  We  herein  present  a rare  case  of  a 77-year-old  female  patient  without  a  cutaneous
lesion, who  underwent  resection  for  what  was  considered  to be  a primary  CFH  of the  lung.  There  has  beenhoracoscopy
ATS
ung tumor
no  recurrence  including  a  cutaneous  lesion  in a year  after  surgery.
DISCUSSION:  CFH  is considered  to be benign,  but rare  cases  showing  multiple  recurrences  and  involving
metastasis  to the  lymph  nodes  and  internal  organs  have  been  reported.  At  present,  it is not possible  to
predict  this  aggressive  biological  behavior  based  on the tumor  histology.
CONCLUSION:  It is  essential  to perform  resection  with  an  adequate  margin  with  close  clinical  follow-up.
© 2016  Published  by Elsevier  Ltd on  behalf  of  IJS Publishing  Group  Ltd.  This  is  an  open  access  article
he CCunder  t
. Introduction
Benign ﬁbrous histiocytoma is a type of ﬁbro-histiocytic tumor
hat commonly occurs in the dermis and the superﬁcial sub-
utis. The tumor is characterized by the tumoral differentiations of
broblasts and histiocytes, the etiology of which is unknown. Cellu-
ar ﬁbrous histiocytoma (CFH), which was ﬁrst described by Calonje
t al., is a distinct variant of ﬁbrous histiocytoma. CFH accounts for
pproximately 5% of cutaneous benign ﬁbrous histiocytomas [1].
n contrast to ordinary ﬁbrous histiocytoma, CFH displays high cel-
ularity, limited polymorphism, a fascicular growth pattern and a
artly storiform pattern. Although it is generally considered to be
 benign tumor, CFH shows a tendency for local recurrence. We
erein present a rare case of a patient with a primary CFH of the
ung.Abbreviations: CFH, cellular ﬁbrous histiocytoma; CT, computed tomography;
ATS, video-assisted thoracoscopic surgery; DFSP, dermatoﬁbrosarcoma protuber-
ns.
∗ Corresponding author at: Department of Chest Surgery, Onga Nakama medical
ssociation Onga hospital, 1725-2 Ooaza-Ozaki Ongacho, Onga-gun, Fukuoka 811-
342, Japan.
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ttp://dx.doi.org/10.1016/j.ijscr.2016.05.011
210-2612/© 2016 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd. This i
rg/licenses/by-nc-nd/4.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
2. Case report
The patient was  a 77-year-old asymptomatic female who  visited
our hospital after an abnormal shadow was detected on a chest X-
ray. She had no history of cutaneous lesions nor did she have any
history of occupational exposure to silica, beryllium, or asbestos.
Chest computed tomography (CT) revealed the presence of a well-
demarcated solid nodule of 2.3 cm in diameter in the right lower
lobe (Fig. 1). A systemic CT examination revealed no tumors other
than this pulmonary tumor.
We  performed a wedge resection of the right lower lobe by
video-assisted thoracoscopic surgery (VATS). Three ports were
placed in the left lateral decubitus position. The lung was  deﬂated
to conﬁrm the right lung nodule. A linear stapling device was  used
to resect the lung nodule. The nodule was  ﬁrm and solid. On sec-
tioning, it appeared yellow-white in color (Fig. 2). A frozen section
revealed the proliferation of ﬁbromuscular tissue with a few mitotic
ﬁgures, suggesting that it was  a mesenchymal tumor. Right lower
lobectomy was performed because malignancy could not be denied
based on the examination of the frozen section. The postoperative
course was  uncomplicated. The histopathological ﬁndings revealed
a well-demarcated nodular lesion with the cellular proliferation of
almost bland-looking spindle or oval histiocytoid cells, arranged
in a storiform or loose fascicular fashion with many branching or
anastomosing blood vessels, sometimes displaying hemangioperi-
cytomatous pattern, in the pulmonary parenchyma. Mitotic ﬁgures
s an open access article under the CC BY-NC-ND license (http://creativecommons.
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iFig. 2. A nodule was  ﬁrm, solid, and yellow-white in color on sectioning.
ere sometimes encountered (Fig. 3A). Immunohistochemically,
any tumor cells were positive for alpha-smooth muscle actin
Fig. 3B), estrogen receptor and progesterone receptor and some
ere also positive for bcl-2 and CD10. A small number of factor
IIIa-positive cells were admixed. The specimens were negative
or CD34, CD68, desmin, cytokeratins (AE1/AE3, CAM5.2), EMA,
-caldesmon, transgelin, CD99, TLE-1 and STAT6 (Fig. 3). In our
olecular assay using formalin-ﬁxed, parafﬁn-embedded tumor
issue specimens, no S18-SSX fusion gene transcript was detectable,
espite the use of ampliﬁable PBGD and PGK gene transcripts as
nternal controls. The lesion was diagnosed based on the features,emarcated solid nodule of 2.3 cm in diameter in the right lower lobe.
which were suggestive of CFH. There has been no recurrence includ-
ing a cutaneous lesion in a year after surgery and the patient’s
condition has remained good.
3. Discussion
CFH represents a morphological variant of ﬁbrous histiocy-
toma, which should be distinguished from dermatoﬁbrosarcoma
protuberans (DFSP) and leiomyoma. Microscopically, CFH shows
high cellularity and is composed of spindle-shaped cells with vari-
able amounts of eosinophilic cytoplasm and small, oval, vesicular
eosinophilic nuclei. The histological ﬁndings of CFH include large
size, higher cellularity with a more fascicular architecture, a focally
smooth muscle-like appearance, a moderate mitotic rate, focal
areas of necrosis or infarction, and limited cellular polymorphism.
Cytological atypia is not a feature. The tumors include lymphocytes,
plasma cells, foamy macrophages and less commonly, giant cells.
Most of these ﬁndings are seen in the cases that we have treated and
these microscopic ﬁndings are thought to be imperative for making
a conclusive diagnosis, as we  did in the present case. Traditionally,
CD34 and factor XIIIa have been widely used in distinguishing CFH
from DFSP [2]. Although CD34 expression was not observed in the
present case, CD34 is observed in up to 20% of CFH cases [2]. Even in
the subset of CFH patients in whom CD34 positivity is not observed,
the tumor can be correctly diagnosed based on the characteristic
morphological features, which readily distinguish CFH from DFSP.
Most CFHs occupy the superﬁcial dermis and extend into the
deep reticular dermis. In this case we diagnosed the lung lesion
as a primary CFH of the lung because no other lesions had been
detected in her body in a year after surgery. It should be noted,
however, that pulmonary CFH lesions are often metastases [3,4].
Our search of literature only revealed one case of primary CFH of the
lung. An 8-year-old boy underwent right middle and lower lobec-
tomy after a 4.0 × 4.0 × 3.0 cm tumor was  located in the median of
the bronchus intermedius. Microscopically, the lesion showed high
cellularity, limited polymorphism, a fascicular growth pattern and
a partly storiform pattern [5].
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cells,  arranged in a storiform or loose fascicular fashion with many branching or ana
ulmonary parenchyma. Mitotic ﬁgures were sometimes encountered (×200). (B) I
lpha-smooth muscle protein (×200). (C) Immunostaining for CD34 showed that tu
Surgical intervention is important, not only for achieving a cure,
ut also as a diagnostic measure to rule out malignancy. Complete
esection alone seems to be a suitable surgical treatment. There is
ncreasing evidence to suggest that patients with CFH experience
ocal recurrence more frequently than those with usual ﬁbrous his-
iocytomas (in whom the recurrence rate is 25%), especially after
ncomplete surgical excision [6]. CFH is considered to be benign,
ut rare cases showing multiple recurrences and involving metas-
asis to the lymph nodes and internal organs have been reported
4,7]. At present, it is not possible to predict this aggressive biolog-
cal behavior based on the tumor histology. It is therefore essential
o perform resection with an adequate margin with close clinical
ollow-up.
We herein presented a rare resected case of a primary CFH of
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redited.sing blood vessels, sometimes displaying hemangiopericytomatous pattern, in the
ostaining for alpha-smooth muscle actin showed that many tumor cells expressed
ells expressed no CD34 protein (×200).
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